DWA
VRDN icon

Dorsey Wright & Associates’s Viridian Therapeutics VRDN Stock Holding History

Dorsey Wright & Associates’s Portfolio VRDN Stock Details VRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,511
Closed -$46K – 327
2022
Q1 		$46K Buy
+2,511
New +$46K 0.01% 220